|
1
|
Alternatively activated macrophages and collagen remodeling characterize the postpartum involuting mammary gland across species.
|
Am J Pathol
|
2010
|
1.65
|
|
2
|
Microenvironment of the involuting mammary gland mediates mammary cancer progression.
|
J Mammary Gland Biol Neoplasia
|
2007
|
1.50
|
|
3
|
Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responses.
|
Clin Cancer Res
|
2004
|
1.36
|
|
4
|
Urinary metalloproteinases: noninvasive biomarkers for breast cancer risk assessment.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
1.16
|
|
5
|
Fusion of dendritic cells with multiple myeloma cells results in maturation and enhanced antigen presentation.
|
Br J Haematol
|
2005
|
0.96
|
|
6
|
Emerging targets for the prevention of pregnancy-associated breast cancer.
|
Cell Cycle
|
2012
|
0.89
|
|
7
|
Breaking down barriers: the importance of the stromal microenvironment in acquiring invasiveness in young women's breast cancer.
|
Breast Cancer Res
|
2009
|
0.89
|
|
8
|
6-Benzylamino 4-oxo-1,4-dihydro-1,8-naphthyridines and 4-oxo-1,4-dihydroquinolines as HIV integrase inhibitors.
|
Bioorg Med Chem Lett
|
2010
|
0.86
|
|
9
|
Molecularly targeted therapy: when to stop and when to continue?
|
Lancet Oncol
|
2010
|
0.82
|
|
10
|
Circulating tumor cells in HER-2 positive metastatic breast cancer patients treated with trastuzumab and chemotherapy.
|
Int J Biol Markers
|
2009
|
0.77
|
|
11
|
A young woman with a small ER-positive breast cancer, a micrometastatic axillary lymph node, and an intermediate oncotype DX recurrence score.
|
Oncology (Williston Park)
|
2007
|
0.77
|
|
12
|
A postmenopausal woman with early-stage breast cancer and borderline hormone-receptor staining.
|
Oncology (Williston Park)
|
2005
|
0.75
|
|
13
|
A woman with primary breast cancer and a solitary sternal metastasis.
|
Oncology (Williston Park)
|
2006
|
0.75
|
|
14
|
Determination of N-acetyl retigabine in dog plasma by LC/MS/MS following off-line microElution 96-well solid phase extraction.
|
J Chromatogr B Analyt Technol Biomed Life Sci
|
2007
|
0.75
|
|
15
|
A perimenopausal woman with a small, ER/HER2-positive, node-negative breast cancer.
|
Oncology (Williston Park)
|
2008
|
0.75
|